Skip to main content
Friday
November 29, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
FRIDAY,
NOVEMBER 29, 2024
Serum Institute of India
Global Economy
Indian vaccine giant Serum plans African plant in global expansion
Coronavirus chronicle
India's Serum Institute applies for full approval of Covishield vaccine
Coronavirus chronicle
'Hope to launch Covavax for adults in October, in early 2022 for kids': Adar Poonwalla
Coronavirus chronicle
Covishield okayed by 7 EU Nations, Switzerland, Iceland
Coronavirus chronicle
SII plans to start clinical trials of Novavax for children in July
Coronavirus chronicle
Can manufacture, supply 90-100 million Covishield doses in June: SII to govt
Bangladesh
'Attempts underway to collect Oxford vaccine from other countries'
Panorama
Adar Poonawalla: Rise of the Vaccine Prince
Coronavirus chronicle
Vaccine prince exposes India’s best and worst
Coronavirus chronicle
India's Serum Institute plans to start vaccine production outside India
Coronavirus chronicle
SII to raise output to 100 mln AstraZeneca doses by July, not end-May
Coronavirus chronicle
WH uncertain over lifting curbs on vaccine raw materials export to India
Coronavirus chronicle
India reports Covid-19 vaccine shortage as second wave surges record highs
Show More